TR199903277T2 - Benzimidazol türevleri. - Google Patents

Benzimidazol türevleri.

Info

Publication number
TR199903277T2
TR199903277T2 TR1999/03277T TR9903277T TR199903277T2 TR 199903277 T2 TR199903277 T2 TR 199903277T2 TR 1999/03277 T TR1999/03277 T TR 1999/03277T TR 9903277 T TR9903277 T TR 9903277T TR 199903277 T2 TR199903277 T2 TR 199903277T2
Authority
TR
Turkey
Prior art keywords
benzimidazole
trevleri
alkyl group
salt
derivative
Prior art date
Application number
TR1999/03277T
Other languages
English (en)
Inventor
Yamasaki Noritsugu
Imoto Takafumi
Oku Teruo
Katayama Akira
Kayakiri Hiroshi
Onomura Osamu
Hiramura Takahiro
Nishikawa Masahiro
Sawada Hitoshi
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of TR199903277T2 publication Critical patent/TR199903277T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

R1'in bir alkil grubu, vs; R2'nin ikameli veya ikamesiz bir aromatik düsük alkil grubu; R3'ün bir alkil grubu, vs. ve -X-'in asagidaki formül (V): vs. oldugu formül: ile ifade edilen yeni bir benzimidazol türevi veya bir tuzu. Bu türevi veya tuzu ilaç olarak tipta kullanabilen yararli bir maddeler.
TR1999/03277T 1997-06-27 1998-06-26 Benzimidazol türevleri. TR199903277T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18769697 1997-06-27
JP7635798 1998-03-25

Publications (1)

Publication Number Publication Date
TR199903277T2 true TR199903277T2 (tr) 2000-07-21

Family

ID=26417500

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03277T TR199903277T2 (tr) 1997-06-27 1998-06-26 Benzimidazol türevleri.

Country Status (15)

Country Link
US (1) US6420409B1 (tr)
EP (1) EP1020452A4 (tr)
KR (1) KR20010014166A (tr)
CN (1) CN1135224C (tr)
AR (1) AR016108A1 (tr)
AU (1) AU748541B2 (tr)
BR (1) BR9811273A (tr)
CA (1) CA2294505A1 (tr)
HK (1) HK1028246A1 (tr)
HU (1) HUP0002324A3 (tr)
IL (1) IL133674A0 (tr)
RU (1) RU2243968C2 (tr)
TR (1) TR199903277T2 (tr)
TW (1) TW453999B (tr)
WO (1) WO1999000373A1 (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9810456A (pt) * 1997-06-27 2001-09-25 Fujisawa Pharmaceutical Co Composto de sulfonamida, método para sua obtenção e seu uso farmacêutico
KR20010052235A (ko) * 1998-04-06 2001-06-25 후지야마 아키라 인돌 유도체
EP1132087A4 (en) * 1998-11-13 2002-06-26 Fujisawa Pharmaceutical Co MEDICINE AGAINST POLYCYSTIC OVARY SYNDROME
US6869950B1 (en) 1998-12-24 2005-03-22 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
US6525067B1 (en) 1999-11-23 2003-02-25 Pfizer Inc Substituted heterocyclic derivatives
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
US6943171B2 (en) 2001-11-09 2005-09-13 Schering Corporation Polycyclic guanine derivative phosphodiesterase V inhibitors
AU2002349673A1 (en) * 2001-12-03 2003-06-17 Takeda Chemical Industries, Ltd. Insulin resistance improving agents
US20030181461A1 (en) * 2002-01-25 2003-09-25 Lautt Wilfred Wayne Use of phosphodiesterase antagonists to treat insulin resistance
NZ536610A (en) * 2002-05-03 2009-02-28 Israel Inst Biolog Res Spiro agonists and antagonists of M1 and M3 muscarinic receptors for treatment of central and peripheral nervous system disorders
AU2003902860A0 (en) * 2003-06-06 2003-06-26 Daicel Chemical Industries, Ltd Benzimidazole compounds
WO2005082414A2 (en) * 2004-03-02 2005-09-09 Astellas Pharma Inc. Concomitant drugs of a sulfonamide and another therapeutic agent
CA2637674A1 (en) * 2006-01-19 2007-07-26 Abbott Laboratories 2-imino-benzimidazoles
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
EP2509941B1 (en) * 2009-12-07 2019-01-23 The Johns Hopkins University N-acylated hydroxylamine derivatives and o-acylated hydroxylamine derivatives
AU2010328230B2 (en) * 2009-12-07 2016-06-02 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives
WO2012102405A1 (ja) 2011-01-28 2012-08-02 佐藤製薬株式会社 縮環化合物
JP6456520B2 (ja) * 2015-12-11 2019-01-23 帝人ファーマ株式会社 アミノアゾール誘導体
WO2017192728A1 (en) 2016-05-03 2017-11-09 Virginia Commonwealth University Heteroatom -doped porous carbons for clean energy applications and methods for their synthesis

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE676196C (de) 1936-08-21 1939-05-30 I G Farbenindustrie Akt Ges Verfahren zur Herstellung von Imidazolverbindungen
US3152142A (en) 1962-05-24 1964-10-06 Dow Chemical Co Benzimidazole compounds
FR2291749A1 (fr) 1974-11-20 1976-06-18 Delalande Sa Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique
JPS51133267A (en) 1975-05-08 1976-11-18 Lilly Co Eli Substituted 11sulphonyl benzimidazole
US4179505A (en) 1977-03-30 1979-12-18 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
US4243806A (en) 1979-06-13 1981-01-06 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
GB2053215B (en) 1979-06-25 1983-04-07 May & Baker Ltd Benzimidazole derivatives
JPS625966A (ja) 1985-07-03 1987-01-12 Nippon Shinyaku Co Ltd ベンズイミダゾ−ル誘導体
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2004911A1 (en) 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
AU7759591A (en) 1990-04-13 1991-11-11 Smithkline Beecham Corporation Substituted benzimidazoles
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5703110A (en) 1990-04-27 1997-12-30 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
RU1836357C (ru) 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5602127A (en) 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5614519A (en) 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
US5594003A (en) 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5407835A (en) 1991-07-31 1995-04-18 Abbott Laboratories Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids
GB9121776D0 (en) 1991-10-14 1991-11-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives and process for preparation thereof
DE4237557A1 (de) 1992-11-06 1994-05-11 Bayer Ag Substituierte Benzimidazole
JPH0853424A (ja) 1994-08-11 1996-02-27 Kureha Chem Ind Co Ltd ベンズイミダゾールスルホン酸アミド誘導体
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
WO1997024334A1 (fr) * 1995-12-28 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Derives du benzimidazole

Also Published As

Publication number Publication date
KR20010014166A (ko) 2001-02-26
RU2243968C2 (ru) 2005-01-10
AU7934698A (en) 1999-01-19
HK1028246A1 (en) 2001-02-09
WO1999000373A1 (fr) 1999-01-07
US6420409B1 (en) 2002-07-16
WO1999000373A8 (fr) 2000-07-20
HUP0002324A2 (hu) 2001-05-28
CN1135224C (zh) 2004-01-21
HUP0002324A3 (en) 2001-07-30
EP1020452A4 (en) 2003-04-02
EP1020452A1 (en) 2000-07-19
AR016108A1 (es) 2001-06-20
CN1268123A (zh) 2000-09-27
TW453999B (en) 2001-09-11
BR9811273A (pt) 2000-07-18
IL133674A0 (en) 2001-04-30
CA2294505A1 (en) 1999-01-07
AU748541B2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
TR199903277T2 (tr) Benzimidazol türevleri.
TR199902552T2 (tr) Fungisidal triflorometilalkilamino-triazolopirimidinler.
PT804200E (pt) Uso de derivados de noribogaina para tratamento de dependencia quimica em mamiferos
DK1177176T3 (da) Triarylsyrederivater som PPAR-receptorligander
DZ2495A1 (fr) Formule nouvelle de l'oméprazole-s.
AR038431A2 (es) Derivados 2-desoxo-15-alquilo de marcfortina
TR199901674T2 (tr)
DE69534502D1 (de) Arylthioverbindungen als antibakterielle und antivirale mittel
SE9702773D0 (sv) Novel compounds
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ATE249440T1 (de) Flüssige benzisochinoline derivate
DE59108419D1 (de) Dicarbonsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide
DE60007745D1 (de) Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe
ATE258930T1 (de) Dihydrobenzifurane
ES2178763T3 (es) 1,3 -bis-(n-lactamil)propanos y su empleo farmaceutico y cosmetico.
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
TR199800714T2 (tr) Yeni [(3-Alkoksi-fenoksi)-etil]-dialkilamin türevleri.
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
TR200001182T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
EP1142880A4 (en) BENZIMIDAZOLE DERIVATIVES
DE59401952D1 (de) Isatinderivate zum färben von keratinhaltigen fasern
TR200101808T2 (tr) Psikotik hastalıkların tedavisi için 3-tetrahidropiridin-4-il indoller
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
ATE229058T1 (de) Verbrückte monoazoverbindungen
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.